✦ LIBER ✦

Modulation of Multidrug Resistance by SDZ PSC 833 in Leukemic and Solid-tumor-bearing Mouse Models

✍ Scribed by Watanabe, Toru ;Naito, Mikihiko ;Oh-hara, Tomoko ;Itoh, Yohjiro ;Cohen, Dalia ;Tsuruo, Takashi

Book ID: 108581322
Publisher: Wiley (Blackwell Publishing)
Year: 1996
Tongue: English
Weight: 590 KB
Volume: 87
Category: Article
ISSN: 0910-5050
DOI: 10.1111/j.1349-7006.1996.tb03157.x

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Comparison of cyclosporin A and SDZ PSC8

Comparison of cyclosporin A and SDZ PSC833 as multidrug-resistance modulators in a daunorubicin-resistant Ehrlich ascites tumor

✍ Ellen Friche; Peter Buhl Jensen; Nis I. Nissen 📂 Article 📅 1992 🏛 Springer 🌐 English ⚖ 379 KB

Reversal of typical multidrug resistance

Reversal of typical multidrug resistance by cyclosporin and its non-immunosuppressive analogue SDZ PSC 833 in Chinese hamster ovary cells expressing themdr1 phenotype

✍ Peter A. W. Boekhorst; Jan Kapel; Martijn Schoester; Pieter Sonneveld 📂 Article 📅 1992 🏛 Springer 🌐 English ⚖ 511 KB

Increased intracellular drug accumulatio

Increased intracellular drug accumulation and complete chemosensitization achieved in multidrug-resistant solid tumors by co-administering valspodar (PSC 833) with sterically stabilized liposomal doxorubicin

✍ Rajesh Krishna; Maryse St-Louis; Lawrence D. Mayer 📂 Article 📅 2000 🏛 John Wiley and Sons 🌐 French ⚖ 221 KB

We have previously demonstrated that liposome encapsulation of doxorubicin (DOX) can alleviate adverse interactions with non-encapsulated DOX and the cyclosporine multidrug-resistant (MDR) modulator Valspodar. We have now investigated the behavior of different liposomal DOX formulations in MDA435LCC